Health
Delta-9 THC: A Guide to its Effects
Delta-9 THC has been the most studied cannabinoid. THC has been proven to have pain-relieving and anti-nausea properties. However, research on its neuroprotective and depression-fighting qualities is still ongoing.
INDUCES EUPHORIA
Many generations of cannabis users have embraced the plant’s mood-enhancing properties, Delta-9 THC. Intoxication with cannabis is unlike any other substance, as it absorbs the mind and body into feelings of joy, relaxation and delight. These euphoric feelings can have a lasting impact on our system. A 2016 study about aggression and cannabis consumption revealed that cannabis decreased aggressive feelings, while alcohol increased them.
ANTINAUSEA PROPERTIES
The well-documented anti-nausea properties of Delta-9 THC are well documented. This was one the first medical benefits that were identified in cannabis. It was established in the 1970s, and 80s. Since 1984, high-thc cannabis strains were prescribed to patients with cancer. It was originally used to treat radiotherapy-induced nausea. Patients today still benefit from THC. The only FDA-approved THC medication is those that treat nausea in patients with cancer.
STIMULATE
The munchies, or an increased hunger feeling after cannabis consumption, is one of the most common side effects. This can be beneficial for people with low appetite. In 2018, a study found that THC increases appetite hormones, including ghrelin (and leptin), and does not affect insulin levels. This is a positive sign for obesity and eating disorders.
ADDICTION TREATMENT
Although it may seem counterproductive to swap a beer for a preroll, THC can help decrease alcoholism and other drug addictions. Legalizing THC does not only reduce alcohol sales but THC intake increases an individual’s chances of success in treatment for opioid addiction. A 2017 study of animals showed that cannabis administration reduced heroin consumption.
NEUROPROTECTIVE PROPERTIES
Delta-9 THC, like other cannabinoids works with the endocannabinoid systems to promote homeostasis. This cannabinoid acts in neuronal cultures of the brain, as an antioxidant. It also encourages neurogenesis (creating more neurons). Delta-9 THC is able to reduce muscle spasms for patients with multiple sclerosis, and slow down the nervous system degradation for patients with Parkinson’s. This is a significant development for patients with neurodegenerative conditions such as Parkinson’s disease.
ANTIDEPRESSANT
A 2020 study showed that almost all 1,819 patients experienced temporary relief from depressive symptoms following cannabis consumption. The authors point out that other studies have shown that cannabis consumption can cause depression. However, this is dependent on the individual and may vary from person to person. If it works for your situation, you can use mother nature’s resources.
Delta-9 THC – How Do You Get it?
THC, like all cannabinoids comes from cannabigerolic (CBGa), which is the “mother” cannabinoids. From CBGa, the compound undergoes an enzymatic reaction called cannabidiolic acid synthase (CBDAS) to become THCa or tetrahydrocannabinolic acid. The heat process of decarboxylation causes THCa to break down to form Delta-9 THC.
Can Delta-9 get you high?
Yes, Delta-9, the most prominent cannabinoid responsible intoxicating and psychoactive effects of cannabis, will make you feel “high”.
What Does Delta-9 Do in the body?
Delta-9 THC is absorbed into your lungs through the gastrointestinal tract. It then enters the bloodstream via your bloodstream. Depending on how the drink was taken, it may interact with your Endocannabinoid System to create intoxicating “high”.
The Endocannabinoid System
The receptors of the endocannabinoid systems are located throughout the body. They help maintain homeostasis by improving biological functions. The ECS is essential for our health.
CB1 receptors are the primary receptors of the ECS. CB2 is the secondary. The brain, nervous system, liver and spinal cord are the main locations of CB1 receptors. CB1 can bind with both the natural cannabinoids and Delta-9 THC.
The delta 9 products that carried at Pure CBD Now come from the same top-rated, reputable brands that you’ve become familiar with over the years.
By Modupe Gbadeyanka
The new one-hour authorisation response time ultimatum policy introduced by the National Health Insurance Authority (NHIA) has received the full backing of SUNU Health Nigeria Limited.
This policy was introduced by the agency to ensure enrollees get prompt approval codes to access care.
Healthcare service providers have been urged to report any Health Maintenance Organisation (HMO) that violates this initiative through an email, with the HMO in copy and a timestamp attached as evidence of the request. They may proceed to offer services to enrollees thereafter.
Speaking at the company’s second-quarter Providers’ Forum for the Lagos-Ogun region in Lagos recently, the chief executive of SUNU Health, Dr Moyosore Olomola, expressed optimism that this policy would improve healthcare delivery in the country, especially for enrollees, who crave quality service.
At the event themed Improving Quality and Access to Care Through Stronger Provider Network, and held at the Nigerian Institute of Medical Research (NIMR) in Yaba, Lagos, Mr Olomola reaffirmed the HMO’s commitment to operating within legal and operational frameworks to guarantee adequate care for enrollees.
“Access to care and quality of care remain key priorities in our healthcare systems. We know quite well that deliberate collaboration, strategic partnerships, and a shared commitment to excellence are required to achieve these priorities.
“A strong provider network is doubtless the backbone of any effective healthcare system. It ensures that our mutual enrollees receive the right care, at the right time, in the right place, and at the right price,” Mr Olomola, represented at the programme by the organisation’s Chief Operating Officer (COO), Dr Faith Nwachi, stated.
He further assured that SUNU Health would strictly adhere to the one-hour authorisation limit, stressing that this aligns seamlessly with one of the organisation’s core values—promptness and its corporate slogan, Humanity is the centre of our initiatives.
In a bid to further improve access and quality of care, SUNU Health also demonstrated its new operational software and Mobile app, aptly named SUNU Legacy.
Also speaking at the event, the NHIA Lagos State Coordinator (Ikeja), Dr Bethuel-Kasimu Abraham, noted that the forum’s expected outcome is to significantly reduce delays in accessing medical care.
Other key expectations include ensuring continuity of care, improving patient outcomes, and strengthening accountability among HMOs.
Addressing specific pain points faced by enrollees, the NHIA Ogun State Coordinator, Mr Dare Adefeso, acknowledged that the agency had received complaints regarding out-of-stock drugs and the discrimination of enrollees by certain providers.
He affirmed that the NHIA is actively addressing these issues, stressing that moving forward, every facility must ensure enrollees are properly catered to regardless of their status, provided they have an active health insurance plan.
Corroborating the long-standing legacy of SUNU Health, the Ogun State Director of the National Orientation Agency (NOA), Mrs Aishat Tiamiyu, shared that her agency is responsible for public information dissemination and has been enrolled with SUNU Health for over 25 years.
Commending the HMO’s stellar service over two decades, she called for the immediate enrollment of new NOA staff into the scheme.
The Providers’ Forum remains one of the strategic channels employed by SUNU Health to consistently engage healthcare providers, understand their operational challenges, introduce new software updates, and solidify partnerships aimed at fostering premium healthcare delivery across Nigeria.
By Aduragbemi Omiyale
The National Agency for Food and Drug Administration and Control (NAFDAC) has announced the recall of a sexual enhancement product known as WAP Sensual Enhancement Capsules.
In a statement on Monday, the Nigerian agency disclosed that the recall is due to “undeclared pharmaceutical ingredients” in the product, whose country of origin is unknown, but is marketed and distributed online in the US through eBay.
It was emphasised that the recall is being “voluntarily” made by the manufacturer, Best Supplements Best Prices Company.
The detection of the undeclared pharmaceutical ingredients was made by the US Food and Drug Administration (FDA).
Laboratory analysis by the US FDA revealed that the product contained undeclared sildenafil, tadalafil, and flibanserin, which were not mentioned on the product label. Such substances may include phosphodiesterase type-5 (PDE-5) inhibitors or related compounds commonly used for the treatment of erectile dysfunction, the statement by NAFDAC stated.
Sildenafil and tadalafil are ingredients in FDA-approved prescription drugs used to treat erectile dysfunction.
It was noted that these undeclared ingredients may interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates.
Flibanserin is the active ingredient in an FDA-approved prescription drug used to treat low sexual desire in women. Flibanserin can cause drowsiness, sedation, dangerously low blood pressure, and fainting, especially when combined with alcohol.
Consumers have been encouraged to report compromised products (medicines or medical devices) to the nearest NAFDAC office, call 0800-162-3322, or send an email to sf******@********ov.ng.
By Modupe Gbadeyanka
Dr Obi Adigwe has been appointed as the pioneer National Coordinator of the National Health Technology and Data Analytics Office (NHTDAO).
The body was created by the Ministry of Health under the approval of President Bola Tinubu.
NHTDAO will be domiciled in the Office of the Coordinating Minister of Health and Social Welfare, a statement on Friday by the Special Adviser to the President on Information and Strategy, Mr Bayo Onanuga, stated.
The agency will serve as a meta-level national platform for coordinating the country’s digital-health agenda. It will reinforce, not replace, the existing statutory functions of relevant departments and agencies, it was emphasised.
The organisation will also harmonise and empower the public and private institutions across the health system, set the standards that connect them, and operationalise the National Digital Health Architecture, approved by the National Council on Health in November 2025.
It was stated that President Tinubu expects NHTDAO to accelerate Nigeria’s transition to a secure, interoperable and data-driven health system that improves outcomes for all citizens.
Mr Adigwe, as Director General of the National Institute for Pharmaceutical Research and Development, has leveraged science to catalyse interventions in artificial intelligence, translational research, and technology transfer.
He coordinated major projects, including the ¥300m Nanotechnology grant and the AFREXIMBank grant for Africa’s first API Training Facility. He led the roadmap development that underpinned an €18 million EU grant, the largest in Africa for the thematic area. During the last pandemic, Adigwe globally showcased African science by undertaking the world’s first analysis to debunk claims about the Covid Organics preparation.
The Office’s Steering Committee, which provides strategic direction and oversight, comprises:
- Professor Muhammad Ali Pate, Coordinating Minister of Health and Social Welfare (Co-chair)
- Mr Olaniyi Yusuf, Chairman of the Nigerian Economic Summit Group (Co-chair)
- Dr Iziaq Adekunle Salako, Minister of State for Health and Social Welfare (Alternate Co-chair)
- Ms Kachollom Daju, Permanent Secretary, Federal Ministry of Health and Social Welfare
- Mr Idris Alubankudi Saliu, Special Adviser to the President on Technology and Digital Economy
- Dr Muntaqa Umar-Sadiq, National Coordinator, SWAp Coordination Office
- Dr Abdu Mukhtar, National Coordinator, Presidential Initiative to Unlock Healthcare Value Chain
- Dr Muyi Aina, Executive Director, National Primary Health Care Development Agency
- Dr Kelechi Ohiri, Director General, National Health Insurance Authority
- Director, Health Planning, Research and Statistics, Ministry of Health and Social Welfare
- National Information Technology Development Agency Representative
- Six representatives of the State Commissioners of Health, one from each of the six geopolitical zones
- Pharm Hamza Buhari, Stakeholder representing Industry and Community.
-
Feature/OPED6 years agoDavos was Different this year
-
Travel/Tourism10 years ago
Lagos Seals Western Lodge Hotel In Ikorodu
-
Showbiz3 years agoEstranged Lover Releases Videos of Empress Njamah Bathing
-
Banking8 years agoSort Codes of GTBank Branches in Nigeria
-
Economy3 years agoSubsidy Removal: CNG at N130 Per Litre Cheaper Than Petrol—IPMAN
-
Banking3 years agoSort Codes of UBA Branches in Nigeria
-
Banking3 years agoFirst Bank Announces Planned Downtime
-
Sports3 years agoHighest Paid Nigerian Footballer – How Much Do Nigerian Footballers Earn